Search

Zdenka Haskova

from Burlingame, CA
Get Report
Also known as:
Zdenka Dr Haskova
Phone and address:
1551 Cypress Ave, Burlingame, CA 94010
Connected to:
Kailyn Haskovec, 32Sally A Haskovec, 58Richard A Haslag, 74Margaret C Haslage, 59Axel Haslam, 42Barbara E Haslam, 87Bruce S Haslam, 74Cameron A Haslam, 94Cecile Haslam, 52Christopher P Haslam, 54

Zdenka Haskova Phones & Addresses

  • 1551 Cypress Ave, Burlingame, CA 94010
  • San Mateo, CA
  • Downingtown, PA
  • 41 Hancock St, Boston, MA 02114 (617) 742-0283
  • 1 Prescott St, Boston, MA 02128 (617) 569-8780
  • Brookline, MA

Work

Company: Genentech Apr 2012 Position: Medical director

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Charles University 1993 to 1997 Specialities: Immunology

Skills

Immunology • Clinical Trials • Clinical Development • Drug Development • Drug Discovery • Oncology • Biotechnology • Pharmacology • Pharmaceutical Industry • Life Sciences • Clinical Research • In Vivo • Biomarkers • Ophthalmology • Cell • Translational Medicine • R&D • Cancer • Monoclonal Antibodies • Medicine • Biopharmaceuticals • Infectious Diseases • Inflammation • Assay Development • Pcr • Pharmacovigilance • Neurology • Translational Research • Transplant • Therapeutic Areas • Cro • Cell Biology • Protein Chemistry • Antibodies • Hematology • Medical Affairs • Metabolism • Medical Writing • Lifesciences • Biomarker Discovery • Vaccines • Internal Medicine • Pharmacokinetics • Ind • Neuroscience • Pharmacodynamics • Molecular and Cellular Biology • Receptor Pharmacology • Research and Development • Angiogenesis

Languages

English • Czech • Slovak • Spanish • Russian

Interests

Education • Science and Technology • Human Rights • Arts and Culture • Health

Industries

Biotechnology

Resumes

Resumes

Zdenka Haskova Photo 1

Medical Director

View page
Location:
1551 Cypress Ave, Burlingame, CA 94010
Industry:
Biotechnology
Work:
Genentech
Medical Director
Gsk Jun 2011 - Apr 2012
Clinical Science Manager, Ophthalmology
Gsk Jan 2006 - Jun 2011
Principal Scientist
Boston Children's Hospital Jul 2003 - Jan 2006
Postdoctoral Fellow In Transplantation Immunology and Vascular Biology
Schepens Eye Research Institute Harvard University Jul 1998 - Jun 2003
Postdoctoral Fellow In Immunology of the Eye
Education:
Charles University 1993 - 1997
Doctorates, Doctor of Philosophy, Immunology Institute For Postgraduate Medical Education 1992 - 1995
Charles University 1986 - 1992
Doctor of Medicine, Doctorates, Medicine
Skills:
Immunology
Clinical Trials
Clinical Development
Drug Development
Drug Discovery
Oncology
Biotechnology
Pharmacology
Pharmaceutical Industry
Life Sciences
Clinical Research
In Vivo
Biomarkers
Ophthalmology
Cell
Translational Medicine
R&D
Cancer
Monoclonal Antibodies
Medicine
Biopharmaceuticals
Infectious Diseases
Inflammation
Assay Development
Pcr
Pharmacovigilance
Neurology
Translational Research
Transplant
Therapeutic Areas
Cro
Cell Biology
Protein Chemistry
Antibodies
Hematology
Medical Affairs
Metabolism
Medical Writing
Lifesciences
Biomarker Discovery
Vaccines
Internal Medicine
Pharmacokinetics
Ind
Neuroscience
Pharmacodynamics
Molecular and Cellular Biology
Receptor Pharmacology
Research and Development
Angiogenesis
Interests:
Education
Science and Technology
Human Rights
Arts and Culture
Health
Languages:
English
Czech
Slovak
Spanish
Russian

Publications

Us Patents

Methods Of Treating Cancer By Administering Human Il-18 Combinations

View page
US Patent:
20090035258, Feb 5, 2009
Filed:
Mar 20, 2008
Appl. No.:
12/052278
Inventors:
Zdenka Haskova - King of Prussia PA, US
Zdenka Ludmila Jonak - King of Prussia PA, US
Stephen H. Trulli - King of Prussia PA, US
Margaret N. Whitacre - King of Prussia PA, US
International Classification:
A61K 38/20
A61P 35/04
US Classification:
424 852
Abstract:
The present invention relates generally to the use of human IL-18 combinations in the treatment of various forms of solid tumors and lymphomas. In particular, the present invention relates to: (1) combinations of human IL-18 with monoclonal antibodies against antigens that are expressed on the surface of cancer cells; and (2) combinations of human IL-18 with chemotherapeutic agents.

Novel Uses

View page
US Patent:
20100111945, May 6, 2010
Filed:
Mar 20, 2008
Appl. No.:
12/532727
Inventors:
Zdenka Haskova - King of Prussia PA, US
Zdenka Ludmila Jonak - King of Prussia PA, US
Stephen H. Trulli - King of Prussia PA, US
John F. Toso - King of Prussia PA, US
Margaret N. Whitacre - King of Prussia PA, US
International Classification:
A61K 39/395
A61P 35/00
US Classification:
4241331, 4241721, 4241421
Abstract:
The present invention relates generally to the use of human IL-18 combinations in the treatment of cancers. In particular, the present invention relates to combination of human IL-18 and an anti-CD20 antibody.

Methods Of Treating Cancer By Administering Human Il-18 Combinations

View page
US Patent:
20100196310, Aug 5, 2010
Filed:
Mar 20, 2008
Appl. No.:
12/532776
Inventors:
Zdenka Haskova - King of Prussia PA, US
Zdenka Ludmila Jonak - King of Prussia PA, US
Stephen H. Trulli - King of Prussia PA, US
Margaret N. Whitacre - King of Prussia PA, US
Assignee:
SMITHKLINE BEECHAM CORPORATION - Philadelphia PA
International Classification:
A61K 38/20
A61P 35/00
US Classification:
424 852
Abstract:
The present invention relates generally to the use of human IL-18 combinations in the treatment of various forms of solid tumors and lymphomas. In particular, the present invention relates to: (1) combinations of human IL-18 with monoclonal antibodies against antigens that are expressed on the surface of cancer cells; and (2) combinations of human IL-18 with chemotherapeutic agents.

Novel Antigen Binding Proteins

View page
US Patent:
20130156779, Jun 20, 2013
Filed:
Sep 2, 2011
Appl. No.:
13/639918
Inventors:
Neil James Clarke - Stevenage, GB
Kyung Oh Johanson - King of Prussia PA, US
Zdenka Ludmila Jonak - King of Prussia PA, US
Alexander H. Taylor - King of Prussia PA, US
Christopher B. Hopson - Collegeville PA, US
Stephen H. Trulli - King of Prussia PA, US
Zdenka Haskova - King of Prussia PA, US
Judithann M. Lee - King of Prussia PA, US
John R. White - King of Prussia PA, US
Yu Xue - King of Prussia PA, US
International Classification:
C07K 16/28
US Classification:
4241391, 5303879, 5303873, 536 2353, 4353201, 435331, 435 696
Abstract:
The present disclosure relates to antigen binding proteins, such as antibodies, that bind to HER3, polynucleotides encoding such antigen binding proteins, pharmaceutical compositions comprising said antigen binding proteins and methods of manufacture. The present disclosure also concerns the use of such antigen binding proteins in the treatment or prophylaxis of diseases associated with breast cancer, ovarian cancer, prostate cancer, bladder cancer, pancreatic, gastric, melanoma and other cancers that overexpress HER3.

Novel Uses

View page
US Patent:
20080274078, Nov 6, 2008
Filed:
Mar 20, 2008
Appl. No.:
12/052120
Inventors:
Zdenka HASKOVA - King of Prussia PA, US
Zdenka Ludmila JONAK - King of Prussia PA, US
Stephen H. TRULLI - King of Prussia PA, US
John F. TOSO - King of Prussia PA, US
Margaret N. WHITACRE - King of Prussia PA, US
International Classification:
A61K 38/20
A61P 35/00
US Classification:
424 852
Abstract:
The present invention relates generally to the use of human IL-18 combinations in the treatment of cancers. In particular, the present invention relates to combination of human IL-18 and an anti-CD20 antibody.
Control profile
Zdenka Haskova from Burlingame, CA Get Report